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Technical breakthroughs have highlighted
the host–microbe interactome to explore
the immune system and the role for
microorganisms in the development and
function of the immune system. While
these interaction studies have provided a
window on the pathogenesis of the disease,
there is a distinct lack of information on
the effect of these interactions in the overall
host physiology. For example, the semi-
nal work conducted in human medicine
demonstrating that subclinical inflamma-
tion has dramatic effects on host physiol-
ogy resulting in diseases such as obesity,
type 2 diabetes, and cardiovascular disease.
This is an area of interest for this jour-
nal. What effects do subclinical infections
have on the pathophysiology of animals
resulting in what is believed to be accept-
able production losses, but may actually be
preventable?
The immune response and nutrient
metabolism are two fundamental biolog-
ical systems indispensable to maintaining
and preserving life. Each of these sys-
tems is capable of modulating the activ-
ity of the other to ensure that the host
animal is capable of coordinating the
appropriate responses under any condi-
tions. Thus, metabolic systems are inte-
grated with pathogen-sensing and immune
responses, and these pathways are evo-
lutionarily conserved. Yet, we know very
little about the effect of infections on
host metabolism. Several important net-
works sense and manage nutrients and
integrate with immune and inflammatory
pathways to influence the physiological and
pathological metabolic states. For exam-
ple, the Toll-like receptors (TLRs), a fam-
ily of the innate sensors, recognize spe-
cific microbial components, but can also
sense nutritional signals, such as elevated
glucose levels and saturated fatty acids.
Likewise, metabolism-signaling pathways,
such as leptin and other hormones, can
also regulate immune functions. Thus, any
immune alteration, specifically inflamma-
tion, can cause disturbances in host metab-
olism. New insights into infectious disease
pathogenesis and animal production that
can result in the discovery of novel diag-
nostic approaches and/or therapeutics are
of high priority for the journal.
The Veterinary Infectious Disease spe-
cialty section seeks to become an outlet for
veterinary research into infectious diseases
through the study of the pathogen or its
host or of the host’s environment, or by
addressing combinations of these aspects
of the disease system. We vision research
in this area will exploit the very latest tech-
nologies to improve our understanding of
the host–pathogen interface or its relation-
ship with the host animal’s environment.
With this in mind, we see the following
areas of research that present needs and
challenges in the immediate future.
SYSTEMS BIOLOGY
The advancement of high-throughput
technologies, together with the extensive
identification of new genes, proteins, and
other biomolecules in the “omics” era,
has facilitated large-scale biological mea-
surements. Cross-talk mechanisms dur-
ing host–pathogen interactions impact the
outcome of infections and further influ-
ence subsequent pathogen exposure. As a
result, genome-wide studies provide global
response patterns to infections from both
the host and pathogen side. However,
biological interpretations of genome-wide
studies are limited to only a fraction of the
theoretically possible interactions between
genes, environmental conditions, and life
cycles taking part in a host–pathogen set-
ting. The enormous complexity underlying
the host–pathogen interplay when con-
sidering the theoretically possible genetic
interactions of even a few genes, necessi-
tates the simplification of systems to cel-
lular or pathway levels. A systems biol-
ogy approach at the genomic, proteomic,
and metabolomic levels is a continually
emerging paradigm to better understand
the pathophysiology of infectious processes
and their underlying mechanisms during
host–pathogen interactions. Systems biol-
ogy connects many disciplines to create a
quantitative and predictive interpretation
of biological processes.
PROTEOMICS
For the most part, veterinary infectious dis-
ease research has focused on DNA analy-
ses. Yet, the execution of the genetic plan
is carried out by the activities of pro-
teins. Gene transcription does not nec-
essarily mean translation; mRNA can be
silenced or destroyed before protein can
be produced. In addition, proper folding,
post-translational modifications, and acti-
vation are central to the proper functioning
of a protein. Post-translational modifica-
tions such as phosphorylation and glycosy-
lation are often extremely important for the
function of many proteins, although most
of these modifications cannot yet be pre-
dicted from genomic or mRNA sequences.
Therefore, effective analytical techniques
for quantitative determination of levels
of protein phosphorylation are therefore
essential tools for studies on the pro-
teome, particularly in relation to infectious
disease interactions, vaccine development,
and drug discovery. For example, large-
scale identification of phosphoproteins is
possible due to advancements in meth-
ods of shotgun proteomics based on mass
spectrometry. On the downside, these tech-
niques require expensive instrumentation
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and involve complicated procedures for
sample preparation through enrichment of
phosphopeptides by enzymatic digestion.
Microarray techniques involving peptide
or protein arrays have demonstrated con-
siderable potential as cost-effective, high-
throughput, and convenient approaches
for defining activities relating to signal
transduction by means of phosphorylation
reactions in a host have been implicated
in a number of infectious human diseases
(1–6). Further, using peptide arrays for
kinome analysis is a new technique to study
host cellular signaling during an infection.
Kinome arrays facilitate parallel analysis
of kinase activities and by comparison of
treatments with and without a pathogen,
one can detect kinases that become acti-
vated and deactivated upon infection (7).
In addition, the use of species-specific pep-
tide arrays for kinomic study provide fur-
ther evidence for understanding mecha-
nisms for host behavior during infection
and can contribute to the rational design
of more effective therapeutics and/or vac-
cines (8). Another under-utilized tech-
nique for use in veterinary infectious dis-
ease proteomics is proteome microarray
analysis. Proteome microarrays provide a
way to map the humoral responses to bac-
terial and viral proteomes; thus identify-
ing proteins that could induce protective
immune responses. These “immune signa-
tures” have recently been shown to be used
to predict vaccine efficacy (9) and design
subunit vaccines for medically important
viral and bacterial infections, respectively.
Further, glycomic arrays are proteomic
tools that are based on the carbohydrate
binding specificities of proteins. Carbohy-
drates are recognized by viruses to invade
host cells, whereas bacteria bind them to
adhere to host cells.
METABOLOMICS
Metabolomics provides a direct indica-
tion of the physiological status of a
host during interactions with a pathogen
by characterizing metabolites produced
during an infection. The metabolic sig-
nature of the infected host represents
the shared events of both host and
pathogen and their metabolic crosstalk.
Metabolomics uses analytical techniques to
simultaneously analyze hundreds to thou-
sands of small-molecule metabolites in
biological samples. In conjunction with
bioinformatics tools, metabolomics should
help explain and predict clinical indica-
tors of infections, host responses, dis-
ease pathogenesis/progression, and disease
outcomes. Characterizing metabolic path-
ways driven by host–pathogen interaction
can be achieved by profiling the down-
stream metabolites regulated indirectly by
upstream genes. Unfortunately, a general
lack of information of pathogen metabo-
lism due to an absence of functional anno-
tation for a large number of genes con-
trolling regulatory metabolic enzymes may
be the limiting factor for rapid progress of
metabolomics in veterinary sciences. Thus,
a great deal of annotation and functional
genomics research is required before wide-
spread adaptation of this omics approach
can be widely utilized in veterinary infec-
tious disease.
miRNAomics
Medical research in infectious diseases and
immunity has been shown to be pro-
foundly influenced by microRNA (miR-
NAs). MiRNAs target and regulate sev-
eral regulatory mRNAs that affect cellular
activities including differentiation of mul-
tiple immune cells, regulation of multiple
pattern recognition receptors (PRR)/NF-
κB inflammatory signaling pathways in
response to infections, and host cell activi-
ties that affect viral, bacterial, and parasitic
colonization, persistence, and pathogene-
sis. Various miRNAs that can be induced or
dysregulated during growth, development,
and immune function have been found in
the genomes of most farm and compan-
ion animals. An immediate research goal
is to elucidate their functions in cellular
processes and veterinary infectious diseases
that would provide a better understand-
ing of the molecular interactions between
host and pathogen. For example, several
human viruses encode miRNAs that down-
regulate the expression of the functional
activities of innate immunity, thus evad-
ing the host defenses. Additionally, many
of these viruses also possess miRNAs to
maintain latent and persistent infections.
Do animal viruses also possess the miR-
NAs and do they function similarly? Like-
wise, what changes in miRNA expression
are induced in the host cells and tissues of
farm and companion animals colonized by
pathogenic bacteria and what role do any
changes in miRNA profiles have in either
repressing or enhancing bacterial repli-
cation and persistence? Answering these
questions can lead to the development
of miRNA-based therapeutic approaches
for the treatment of infectious diseases
through either the restoration or repression
of pathogen-specific miRNA expression
and activity.
INNATE IMMUNITY
The host immune response to pathogens
in the earliest stages of infection is a
critical determinant of disease resistance
and susceptibility. These early responses
are mediated by the innate immune sys-
tem, a rapidly induced, phylogenetically
conserved response of all multicellular
organisms that depends upon a collec-
tion of germ-line-encoded PRRs for detec-
tion of microbe-associated molecular pat-
terns (MAMPs) on or in major groups
of microbes (10) or damage-associated
molecular patterns (DAMPs). Sensing of
MAMPs or DAMPs induces various extra-
cellular activation cascades and intra-
cellular signaling pathways, leading to
the inflammatory response, recruitment
of phagocytic cells for clearance of the
pathogens, and mobilization of profes-
sional antigen-presenting cells.
Recent research in veterinary and med-
ical infectious diseases have identified
and characterized common and species-
specific PRRs, signaling cascades, gene
expression changes, and production of a
range of host defense and inflammatory
factors. The most studied and character-
ized family of innate receptors in veteri-
nary species is the TLRs although viral
research has also revealed the presence of
the retinoic-acid inducible gene-I (RIG-I)-
like receptors (viral RNA) as well. Fungal
disease research has also revealed the pres-
ence of membrane bound C-type lectin
receptors, which recognize mannan and
β-glucan molecules. However, in general,
there has been a lack of reports detail-
ing the presence and function of several
classes of cytosolic PRRs. The NOD-like
receptors (NLR) and PYHIN protein family
bind bacterial and viral moieties and form
a cytoplasmic signaling complex known
as the inflammasome that initiates acti-
vation of the protease precursor procas-
pase 1 to cleave proIL-1β and proIL-18
prior to their secretion as active inflam-
matory cytokines. The challenge here is
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to identify whether food and compan-
ion animals have these PRRs, character-
ize the pathogens and ligands that lead
to inflammasome assembly, and what role
they play in host defense against infec-
tions. Obviously, identification of inflam-
masomes and their functions can pro-
vide new targets for novel therapeutics in
veterinary medicine.
Two other high priority areas of innate
immunity research in veterinary infectious
diseases that are lacking and could serve
as the basis for future alternative thera-
peutics: (a) the emergence of “patterns of
pathogenesis” as novel pathogen-induced
inducers of innate immune responses and
(b) modulation of innate immune system
as an alternative to antimicrobials.
PATTERNS OF PATHOGENESIS
The epithelial cells lining the mucosal
barriers are a critical component of a
communications network that is essen-
tial for transmitting signals generated
in response to infection with microbial
pathogens to cells of the innate and
acquired immune systems. Because of these
functions, the epithelium is considered
as a “microbial sensor.” Like professional
immune cells, epithelial cells recognize
MAMPs and DAMPS to induce an innate
response. However, the canonical PRR-
MAMP (DAMP) cascades described above
(TLR, NOD, RIG, C-type lectin) do not
provide the epithelial cells with the dis-
criminatory ability to differentiate between
pathogenic and non-pathogenic microbes
to which they are consistently exposed.
It has been hypothesized that these cells
require other sensors that can detect cel-
lular perturbations or damage, which are
triggered by pathogenic microbes but not
commensals. It is these host cell perturba-
tions that form the basis for a new concept
on innate immune recognition and acti-
vation: patterns of pathogenesis (11). The
patterns of pathogenesis concept expand
innate recognition of MAMPs and sensing
of DAMPS to include host detection of nat-
ural infection tactics used by pathogens to
“infect, multiply within, and spread among
their host” (11). These patterns would
include growth (replication), cytosol access
(pore formation and membrane damage),
disruption of host cytoskeleton (secretion
systems, toxins), and the newly identified
pathogen-induced translation inhibition
(12–14). These tactical infection patterns
can then be used by non-professional
immune cells to detect and to discriminate
pathogenic and non-pathogenic microor-
ganisms thereby directing specific immune
responses. Identifying and/or confirming
that such innate sensors exist veterinary
species would be significant for pathogen
diagnosis and development of future ther-
apeutics and vaccines.
ALTERNATIVE TO ANTIMICROBIALS –
MODULATION OF INNATE IMMUNITY
Drug-resistant microorganisms pose an
enormous threat to both veterinary and
public health with an increasing rate of
antimicrobial resistance being reported
worldwide. The frequency of resistance is
presumably due to extensive use of antibi-
otics as growth promoters in veterinary
medicine has led to the emergence of
multi-drug-resistant (MDR) strains that
may pass from food animals to humans.
In addition, fewer novel antibiotics are
being developed to treat infectious diseases.
Therefore, there is an increasing need to
identify alternative approaches associated
with less resistance. Current antimicrobial
therapies target pathogen viability; while
this approach is effective at eliminating
the infectious agent, long-term treatment
selects for resistant organisms. In addi-
tion to this increase in resistant organ-
isms, normal flora beneficial to health can
be adversely affected by antibiotic treat-
ment. Alternative approaches for research
should involve targeting (a) the host or
host–pathogen interface rather than the
pathogen and (b) facilitating pathogen-
specific immune responses.
TARGETING THE HOST–PATHOGEN INTERFACE
A way to diminish the threat to human
health would be to develop antimicrobial
drugs that attack pathogens only without
causing an imbalance in the normal bac-
terial flora. By using virulence factors as
targets for novel anti-infectives, the prob-
ability for development of resistance may
be low since resistance to compounds tar-
geting the virulence factors cannot evolve
and spread in the resident flora, as these
bacteria lack virulence targets. We also pro-
pose that resistance to virulence-blocking
agents is likely to result in non-functional
virulence systems, and thus non-virulent
microbes. Further, as long as the target
remains, extracellular resistance cannot
emerge through the activity of microbial
efflux pumps. Finally, there will be a low
selective pressure for mutations affecting
the specific interaction between the drug
and a virulence factor, as virulence block-
ers should have low effect on microbial
growth.
TARGETING THE HOST INNATE IMMUNE
SYSTEM
A fundamentally new strategy for the
treatment of pathogens in food animals
is to alter host immune responses to
enhance the clearance of infectious agents
and prevent or reduce tissue damage
due to inflammation. Unlike conventional
antibiotics that are designed to target a
pathogen, modulating the immune sys-
tem exert their protective effects by acting
on the host. Vaccines are still the defin-
itive immune-based prophylactic strat-
egy for human and veterinary infectious
agents. Yet, modern veterinary vaccines
have multiple inadequacies including lack
of cross-protection against several different
strains of a pathogen, multi-antigenicity
of pathogens, slow development of pro-
tective immunity (days versus hours), lack
of adequate adjuvants, and a need for site-
specific immune responses that require fur-
ther advances in infection immunobiology
to address these challenges and improve
efficacy.
This is an exciting time to be conducting
research in veterinary infectious diseases.
The tools and technologies are becom-
ing more available for use in veterinary
species. It is my hope that the Section Vet-
erinary Infectious Diseases in Frontiers in
Veterinary Science becomes a primary out-
let for the cutting edge research sure to
come.
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